Scollr summary
What this paper is about
Low transfer to haemodialysis and death rates in this cohort support the safety of incremental PD prescribing, and younger age, male sex, and lower albumin at dialysis start are associated with a shorter time to increment.
Full abstract
Read the full abstract
INTRODUCTION: Incremental peritoneal dialysis (PD), where 'less than full-dose' prescriptions are increased as residual kidney function declines, contributes to increased quality of life and reduced dialysis burden. Evidence supporting the safety of incremental regimens and informing patient expectations is limited. This study examined time to increment in dialysis prescriptions, PD modality transfer, transfer to haemodialysis and mortality rates within a single centre delivering incremental PD. METHODS: Patients incident to PD and on incremental regimens were followed for changes in prescription, modality transfer and death between January 1, 2012 and December 31, 2023. Multivariable Cox regression assessed factors associated with time to increment, and Kaplan-Meier methods with log-rank testing were used for time-to-event analyses. RESULTS: The cohort included 527 patients. At one year, 64% (95% CI 60-69%) remained on the same starting regimen, with 36% of people (95% CI 31-41%) having not incremented by two years. Time to increment was shorter for younger age at PD start (per decade, HR 0.92, 95% CI 0.85-0.99, P=0.02), male sex (HR 1.67, 95% CI 1.29-2.16, P<0.001), and lower serum albumin (HR 0.96, 95% CI 0.94-0.98, P<0.001). PD modality transfer was driven by lifestyle, fluid overload and uraemic symptoms. Transfer to haemodialysis was associated with younger age (P=0.03) and diabetes mellitus (P=0.04), whilst time to haemodialysis transfer was correlated with lower albumin (P=0.01) and starting estimated glomerular filtration rate (P=0.006). Mortality rates were low at 0.11 events per person-year. CONCLUSION: Younger age, male sex, and lower albumin at dialysis start are associated with a shorter time to increment. Low transfer to haemodialysis and death rates in this cohort support the safety of incremental PD prescribing. A simple clinical score was subsequently constructed and tested as a method of supporting shared decision-making and informing patient expectations of treatment but requires validation in future studies.
Direct answer
What can I do from this paper page?
Use this page to scan "Evaluating Patterns and Outcomes in the Prescription of Incremental Peritoneal Dialysis in Support of Shared Decision-Making" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Dialysis and Renal Disease Management research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Selwood2026Evaluating,
title = {Evaluating Patterns and Outcomes in the Prescription of Incremental Peritoneal Dialysis in Support of Shared Decision-Making},
author = {Jessica Selwood and Rishana Shuaib and Ted J. FitzGerald and Sally Punzalan and Gaetano Lucisano and Edwina A. Brown and Richard Corbett},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
doi = {10.2215/cjn.0000001187},
url = {https://doi.org/10.2215/cjn.0000001187}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Dialysis and Renal Disease Management research papers?
Follow Dialysis and Renal Disease Management research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Evaluating Patterns and Outcomes in the Prescription of Incremental Peritoneal Dialysis in Support of Shared Decision-Making. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app